Long term outcomes support complete revascularization in multivessel patients undergoing acute coronary syndrome (ACS). This large contemporary registry...

solaci - 7 August, 2020

Acute coronary syndromes

Webinar SOLACI | NSTE-ACS Revascularization: Times and Methods in the COVID-19 Era

Watch again our Webinar on “NSTE-ACS Revascularization: Times and Methods in the COVID-19 Era” on our Youtube account. We...

solaci - 24 July, 2020

Acute coronary syndromes

European Association of Percutaneous Cardiovascular Interventions Position Statement During the Pandemic

This document emerges from the assembly of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the...

solaci - 16 July, 2020

Acute coronary syndromes

EuroPCR 2020 | FABOLUS FASTER: In the Quest for the Fastest, Most Potent Platelet Inhibition

This small study tested the pharmacodynamic effects of several antiplatelet agents. It concluded that tirofiban (Aggrastat) provides...

solaci - 10 July, 2020

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Transcatheter Deep Vein Arterialization in Critical Limb Ischemia Without Revascularization Options

Dr. Juan Manuel Pérez - 12 February, 2026 0

Chronic limb-threatening ischemia in patients without conventional revascularization options represents one of the most challenging scenarios within peripheral arterial disease, with 1-year major amputation...

Transcatheter Paravalvular Leak Closure: Mid-Term Outcomes and Prognostic Factors

Dr. Andrés Rodríguez - 11 February, 2026 0

Paravalvular leaks (PVL) are a frequent complication following surgical valve replacement, occurring in 5% to 18% of prosthetic valves. Incidence varies according to valve...

After a Major Bleeding Event in Atrial Fibrillation: When Should Left Atrial Appendage Closure Be Considered?

Dr. Juan Manuel Pérez - 10 February, 2026 0

Atrial fibrillation (AF) in patients who experience a major bleeding event represents a complex clinical scenario in which percutaneous left atrial appendage closure (LAAC)...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad

Acute coronary syndromes

LATAM: Information on the Impact of the Pandemic with a Focus on MI

Early Activation to Speed-Up Treatment of Infarcted Patients

Is Medical Treatment Better at Lowering Bleeding-Caused Mortality than Angioplasty?

Infarction, Stroke and Aortic Emergency Syndromes in the Shadow of the Pandemic

Long Term Changes ACS Revascularization

Webinar SOLACI | NSTE-ACS Revascularization: Times and Methods in the COVID-19 Era

European Association of Percutaneous Cardiovascular Interventions Position Statement During the Pandemic

EuroPCR 2020 | FABOLUS FASTER: In the Quest for the Fastest, Most Potent Platelet Inhibition

Últimas Noticias

Transcatheter Deep Vein Arterialization in Critical Limb Ischemia Without Revascularization Options

Transcatheter Paravalvular Leak Closure: Mid-Term Outcomes and Prognostic Factors

After a Major Bleeding Event in Atrial Fibrillation: When Should Left Atrial Appendage Closure Be Considered?

Noticias Institucionales

Fellow’s Corner 2026 – Submit Your Clinical Case

Watch Again: Cardiovascular Risk Factors in Women | SOLACI Technicians Webinar

Technical Training in Hemodynamics and Interventional Cardioangiology | SOLACI–CACI

Accesos